Glaucoma

Inflammatory Glaucoma

Unlock FRCOphth Part 2 Study Notes to access this content.

Get access

Raised IOP in the context of intraocular inflammation: can be challenging

Note: pilocarpine can increase breakdown of blood-aqueous barrier and worsen inflammation

Open angle

  • Acute trabeculitis: associated with herpetic disease

  • Trabecular meshwork blockage

  • IOP tends to normalise after inflammation settles

  • Chronic: may be due to trabecular scarring or chronic trabeculitis

    • Managed as per POAG albeit with poorer outcomes
  • Steroid-induced

    • Risk increases with longer steroid usage (30% after 6 weeks of topical steroid)

    • Increased risk with

      • Myopia
      • POAG (90% steroid response compared to 30% in normal eyes)
      • Diabetes
    • Mechanisms

      • Prostaglandin inhibition
      • Structural changes in the ECM and TM
    • Requires reduction in potency and frequency of topical steroids (compared to the need to increase the steroids in trabeculitis!)

    • May be dose-dependent

      • Topical and intravitreal steroids have highest risk (intravenous, parenteral and inhaled have lowest risk)

Angle-closure

  • Seclusio pupillae: 360 of posterior synechiae leading to iris bombe and appositional angle closure

    • Aim to minimize PS formation while treating attacks of uveitis
    • Laser PI: needs to be larger than in AACG
  • Synechial closure: peripheral anterior synechiae leading to angle closure

    • Associated with granulomatous inflammation
    • Laser PI
    • Other management as for POAG
  • Uveal effusion: anterior rotation of ciliary body

  • Exudative RD pushing iris-lens forwards (rare)

Posner-Schlossman syndrome

  • Recurrent unilateral painless high IOP

  • White eye

  • Typically affects young females

  • Possibly related to HSV trabeculitis

  • 40% are HLA-B54 positive

  • Clinical features

    • Visual blurring
    • Haloes
    • Minimal flare/occasional cells/KPs
    • No synechiae
    • Open angle on gonioscopy
  • Management

    • Topical steroid
    • Topical IOP-lowering therapy

Fuchs’ heterochromic cyclitis/uveitis

  • Mild chronic anterior uveitis

  • Iris heterochromia: usually the lighter iris is the involved eye (diffuse iris stromal atrophy)

  • Cataract

  • Glaucoma in 10-30%: may be difficult to control

  • Affects young adults

  • M=F

  • >90% unilateral

  • Associated with rubella

  • Clinical features

    • White eye
    • Stellate KPs widespread over endothelium
    • Mild AC activity
    • Iris atrophy (‘moth-eaten’)
      • Transillumination defects
    • Iris heterochromia: ‘becoming bluer’
    • Iris nodules
    • Cataract: especially posterior cortical/subcapsular
    • Vitritis
    • Open angle with ‘twig-like’ neovascularisation on gonioscopy: may bleed after paracentesis during cataract surgery (Amsler-Verrey sign)
  • Management as for POAG if relevant. Does not normally require treatment for inflammation

Was this page helpful?

Previous
Neovascular Glaucoma